Advertisement
Advertisement
U.S. markets open in 31 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.03+0.87 (+9.50%)
At close: 04:00PM EDT
10.07 +0.04 (+0.40%)
Pre-Market: 08:51AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close9.16
Open9.18
Bid6.00 x 800
Ask10.79 x 3200
Day's Range9.18 - 10.65
52 Week Range6.05 - 45.56
Volume383,061
Avg. Volume203,491
Market Cap468.54M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.36
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.43
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for GLUE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Monte Rosa Therapeutics, Inc.
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
Advertisement
Advertisement